MYX mayne pharma group limited

Ann: 2022 Half Year Investor Presentation, page-104

  1. 1,471 Posts.
    lightbulb Created with Sketch. 289
    Perhaps there is interest in this business if only for its asset value . If we were to go under buying MYX off our lenders would be a much preferable option than some TO offer . Continuing as a going concern if E4 fails to deliver our lenders would be unlikely to support us much longer and cant see investors wearing another Capital raising . We appear to have assets with sufficient equity to support lending for now but we can be sure our assets would be under close scrutiny by our lenders , obviously would be conservatively valued to safeguard their security . Anyone's guess our true position which surely most be precarious , board in the best position to know this share value fallen as much as it has , directors they're not buying even as a show of confidence , think thy're about as confident as many of us retail holders are .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.07
Change
0.050(1.00%)
Mkt cap ! $411.9M
Open High Low Value Volume
$5.00 $5.14 $4.94 $712.4K 141.2K

Buyers (Bids)

No. Vol. Price($)
1 1059 $5.07
 

Sellers (Offers)

Price($) Vol. No.
$5.13 1000 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.